EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

People living with HIV display increased anti-apolipoprotein A1 auto-antibodies, inflammation, and kynurenine metabolites: a case–control study

Miguel A Frias, Sabrina Pagano, Nasim Bararpour, Jonathan Sidibé, Festus Kamau, Vanessa Fétaud-Lapierre, Peter Hudson, Aurélien Thomas, Sandrine Lecour, Hans Strijdom, Nicolas Vuilleumier

Frontiers in Cardiovascular Medicine · 13.02.2024 · 11

DOI: 10.3389/fcvm.2024.1343361 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Frontiers in Cardiovascular Medicine, online erschienen am 13.02.2024. Verfasst von Miguel A Frias und 10 weiteren Autor:innen. Beteiligte Einrichtung: Division of Laboratory Medicine, Diagnostic Department, Geneva University Hospitals, Geneva, Switzerland. Die Arbeit wurde bisher 10-mal zitiert (Crossref) und nennt 57 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Objective

This study aimed to study the relationship between auto-antibodies against apolipoprotein A1 (anti-apoA1 IgG), human immunodeficiency virus (HIV) infection, anti-retroviral therapy (ART), and the tryptophan pathways in HIV-related cardiovascular disease.

Design

This case–control study conducted in South Africa consisted of control volunteers ( n = 50), people living with HIV (PLWH) on ART ( n = 50), and untreated PLWH ( n = 44). Cardiovascular risk scores were determined, vascular measures were performed, and an extensive biochemical characterisation (routine, metabolomic, and inflammatory systemic profiles) was performed.

Methods

Anti-apoA1 IgG levels were assessed by an in-house ELISA. Inflammatory biomarkers were measured with the Meso Scale Discovery® platform, and kynurenine pathway metabolites were assessed using targeted metabolomic profiling conducted by liquid chromatography-multiple reaction monitoring/mass spectrometry (LC-MRM/MS).

Results

Cardiovascular risk scores and vascular measures exhibited similarities across the three groups, while important differences were observed in systemic inflammatory and tryptophan pathways. Anti-apoA1 IgG seropositivity rates were 15%, 40%, and 70% in control volunteers, PLWH ART-treated, and PLWH ART-naïve, respectively. Circulating anti-apoA1 IgG levels were significantly negatively associated with CD4+ cell counts and positively associated with viremia and pro-inflammatory biomarkers (IFNγ, TNFα, MIPα, ICAM-1, VCAM-1). While circulating anti-apoA1 IgG levels were associated with increased levels of kynurenine in both control volunteers and PLWH, the kynurenine/tryptophan ratio was significantly increased in PLWH ART-treated.

Conclusion

HIV infection increases the humoral response against apoA1, which is associated with established HIV severity criteria and kynurenine pathway activation.

Schlagwörter

Stichwörter der Autor:innen

HIVanti-apolipoprotein A1 auto-antibodiesanti-retroviral therapyautoimmunitycardiovascular diseasekynurenine pathway metabolites

Autor:innen und Institutionen

  • Division of Laboratory Medicine, Diagnostic Department, Geneva University Hospitals, Geneva, Switzerland.
  • Department of Medical Specialties, Faculty of Medicine, University of Geneva, Geneva, Switzerland.
  • Faculty Unit of Toxicology, CURML, Faculty of Biology and Medicine, University of Lausanne, Lausanne, Switzerland.
  • Department of Genetics, Stanford University, Stanford, CA, United States.
  • Stanford Center for Genomics and Personalized Medicine, Stanford, CA, United States.
  • Centre for Cardiometabolic Research in Africa, Division of Medical Physiology, Faculty of Medicine and Health Sciences, Stellenbosch University, Cape Town, South Africa.

Zitieren

APA

Frias, M. A., Pagano, S., Bararpour, N., Sidibé, J., Kamau, F., Fétaud-Lapierre, V., Hudson, P., Thomas, A., Lecour, S., Strijdom, H., & Vuilleumier, N. (2024). People living with HIV display increased anti-apolipoprotein A1 auto-antibodies, inflammation, and kynurenine metabolites: a case–control study. Frontiers in Cardiovascular Medicine, 11. https://doi.org/10.3389/fcvm.2024.1343361

Vancouver

Frias MA, Pagano S, Bararpour N, Sidibé J, Kamau F, Fétaud-Lapierre V, et al. People living with HIV display increased anti-apolipoprotein A1 auto-antibodies, inflammation, and kynurenine metabolites: a case–control study. Frontiers in Cardiovascular Medicine. 2024;11. doi:10.3389/fcvm.2024.1343361

BibTeX
@article{Frias2024,
  author = {Frias, Miguel A and Pagano, Sabrina and Bararpour, Nasim and Sidibé, Jonathan and Kamau, Festus and Fétaud-Lapierre, Vanessa and Hudson, Peter and Thomas, Aurélien and Lecour, Sandrine and Strijdom, Hans and Vuilleumier, Nicolas},
  title = {People living with HIV display increased anti-apolipoprotein A1 auto-antibodies, inflammation, and kynurenine metabolites: a case–control study},
  journal = {Frontiers in Cardiovascular Medicine},
  year = {2024},
  volume = {11},
  doi = {10.3389/fcvm.2024.1343361}
}
Kostenlos starten →